Skip to main navigation Skip to search Skip to main content

Multilocus polymerase chain reaction restriction fragment-length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): Taxonomic and clinical applications

  • Marlene Rozas
  • , Simonne De Doncker
  • , Vanessa Adaui
  • , Ximena Coronado
  • , Christian Barnabé
  • , Michel Tibyarenc
  • , Aldo Solari
  • , Jean Claude Dujardin
  • Universidad de Chile
  • Institute of Tropical Medicine
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
  • Université de Toulouse

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

Background. Trypanosoma cruzi, the agent of Chagas disease, is subdivided into 6 discrete typing units (DTUs); their identification is important to understand clinical pleomorphism and track sylvatic DTUs that might (re-)invade domestic foci of the disease and jeopardize the running control programs. Methods. The genetic polymorphism of 12 loci was analyzed by multilocus polymerase chain reaction restriction fragment-length polymorphism (PCR-RFLP) analysis (MLP analysis) in a sample representative of the diversity within T. cruzi. We paid particular attention to genes involved in host-parasite relationships, because these may be prone to polymorphism as an adaptive answer to the immune selective pressure. Results. The results of MLP analysis were shown to agree with the current multilocus enzyme electrophoresis-and random amplified polymorphic DNA-based classification of T. cruzi in 6 DTUs, thereby providing a taxonomic validation of our method. Our data supported hypotheses of genetic recombination within T. cruzi. We demonstrated direct applicability of PCR-RFLP analysis to blood of mammal hosts and intestine content of vector insects. Domestic DTUs were encountered in wild animals, and, reciprocally, sylvatic DTUs were encountered in humans, raising questions about changes of transmission patterns. Conclusions. MLP analysis represents a new alternative to existing molecular methods for T. cruzi typing. It might offer an invaluable support to clinical and epidemiological studies and to control programs.

Original languageEnglish
Pages (from-to)1381-1388
Number of pages8
JournalJournal of Infectious Diseases
Volume195
Issue number9
DOIs
StatePublished - 1 May 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Multilocus polymerase chain reaction restriction fragment-length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): Taxonomic and clinical applications'. Together they form a unique fingerprint.

Cite this